Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-19 Sale | 2025-12-22 4:02 pm | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 35,389 | $0 | $0 | 2,974,551 (Indirect Direct) | View |
| 2025-12-08 Sale | 2025-12-10 4:29 pm | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 202,908 | $14.85 | $3,012,462 | 2,974,551 (Indirect Direct) | View |
| 2025-09-02 Sale | 2025-09-04 4:01 pm | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 48,978 | $0 | $0 | 3,010,992 (Indirect Direct) | View |
| 2025-01-20 Sale | 2025-01-22 9:55 pm | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 111,949 | $0 | $0 | 3,012,448 (Indirect Direct) | View |
| 2024-02-27 Sale | 2024-02-29 7:53 pm | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 118,922 | $55 | $6,540,710 | 2,967,554 (Indirect Direct) | View |
| 2024-02-20 Sale | 2024-02-22 6:32 pm | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 21,078 | $57.33 | $1,208,418 | 3,086,476 (Indirect Direct) | View |
| 2024-02-14 Sale | 2024-02-16 6:02 pm | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 60,000 | $60.91 | $3,654,800 | 3,107,554 (Indirect Direct) | View |
| 2023-10-01 Sale | 2023-10-03 7:27 pm | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 2,569,458 | $0 | $0 | 202,152 (Indirect Direct) | View |
| 2023-04-05 Sale | 2023-04-07 4:05 pm | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 598,096 | $0 | $0 | 2,847,994 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-07 Option Award | 2026-01-09 4:01 pm | N/A 2036-01-07 | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 520,342 | $0 | 520,342 (Direct) | View |
| 2025-12-19 Conversion | 2025-12-22 4:02 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 36,441 | $0 | 2,974,551 (Direct) | View |
| 2025-01-20 Conversion | 2025-09-04 4:01 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 50,434 | $0 | 3,010,992 (Direct) | View |
| 2025-02-27 Option Award | 2025-03-03 9:07 pm | N/A 2035-02-27 | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 139,273 | $0 | 139,273 (Direct) | View |
| 2025-01-20 Conversion | 2025-01-22 9:55 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 115,277 | $0 | 3,012,448 (Direct) | View |
| 2023-10-01 Conversion | 2023-10-03 7:27 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 2,645,842 | $0 | 202,152 (Indirect) | View |
| 2023-04-05 Conversion | 2023-04-07 4:05 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 615,876 | $0 | 2,847,994 (Indirect) | View |
Ownership | 2022-04-15 4:07 pm | N/A N/A | MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer | 0 | $0 | 3,463,870 (Indirect) | View |